A phase I trial and pharmacokinetic (PK) study of vorinostat (SAHA) in combination with 13 cis-retinoic acid (13cRA) in children with refractory neuroblastomas, medulloblastomas, primitive neuroectodermal tumors (PNETs), and atypical teratoid rhabdoid tumor
- Authors:
- M Fouladi, JR Park, J Sun, AM Ingle, MM Ames, CF Stewart, R Gilbertson, JA Zwiebel, PC Adamson, SM Blaney
- Journal:
- Journal of Clinical Oncology
- Citation info:
- 26(15_suppl):10012-10012
- Publication date:
- 20th May 2008
- Full text
- DOI